Alnylam Pharmaceuticals, Inc.ALNYNASDAQ

Overview Intelligence Charts News Fundamentals Key Metrics Financials Growth Insiders

Loading chart...

Prev Close

327.30

Day Range

322.11-324.98

Volume

461K

Market Cap

42.8B

P/E

141.0

52-Week Range206-496

205.87Current 322.99495.55

Alerts

Quick Start

1. Track ALNY with alerts 2. Compare ALNY vs SPY 3. Open key fundamentals chart

Want to monitor ALNY?

Get notified when price crosses targets, volume spikes, or RSI hits oversold

Create free account to monitor ALNY

Key Statistics

Volume Distribution

About

alnylam is developing an entirely new class of innovative medicines based on a breakthrough discovery in biology known as rna interference, or rnai. with rnai technology, we have the opportunity to treat disease and impact the lives of patients in a fundamentally new way by silencing disease-causing genes upstream of today's medicines.

Sector

Professional, Scientific, and Technical Services

Industry

Research and Development in Biotechnology (except Nanobiotechnology)

CEO

John Maraganore

alnylam.com/ →